Advertisements



We are Sorry, This Page doesn't Exist


Why Melinta Therapeutics Shares Are Getting Crushed

Melinta Therapeutics saw its shares plunge on Thursday after the firm announced that it had priced a secondary offering......»»

Category: blogSource: 247wallstMay 24th, 2018

Nabriva Therapeutics 18.182M share Secondary priced at $2.75

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 26th, 2018

How Proteostasis Will Capitalize on Its Big Cystic Fibrosis Win

Proteostasis Therapeutics shares pulled back on Tuesday after the company announced that it would be conducting a secondary offering......»»

Category: blogSource: 247wallstOct 23rd, 2018

How Global Blood Therapeutics Is Capitalizing on Its Sickle Cell Disease Approval

GBT shares dipped on Friday after the company announced that it would be conducting a secondary offering. This offering comes on the heels of a key FDA approval......»»

Category: blogSource: 247wallstDec 7th, 2018

PTC Therapeutics: Opportunity After Secondary Offering?

PTC Therapeutics: Opportunity After Secondary Offering?.....»»

Category: topSource: seekingalphaJan 25th, 2019

Why A Secondary Offering Is Often Negative For Stocks

Shares of biotechs Sienna Biopharmaceuticals Inc (NASDAQ: SNNA) and Ovid Therapeutics Inc (NASDAQ: OVID) were read more.....»»

Category: blogSource: benzingaFeb 20th, 2019

Seelos Therapeutics 19.35M share Spot Secondary priced at $3.10

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 20th, 2021

Purple Innovations shares fall 10% premarket after secondary offering of 7.3 million shares

Purple Innovation Inc. shares tumbled 10% in premarket trade Wednesday, after the mattress and sleep products company priced a seco.....»»

Category: topSource: marketwatchMay 19th, 2021

Acute care telemedicine provider SOC Telemed files for secondary offering

SOC Telemed Inc. , a provider of acute care telemedicine services and technology to U.S. hospitals and healthcare sys.....»»

Category: topSource: marketwatchMay 18th, 2021

The Funded: Bay Area biotech Vera Therapeutics" IPO priced well short of targets, another sign of a worsening market

Vera's disappointing offering follows several others that have been postponed or also missed their price targets......»»

Category: topSource: bizjournalsMay 14th, 2021

The Funded: Bay Area biotech Vera Therapeutics" IPO just well short of targets, another sign of a worsening market

Vera's disappointing offering follows several others that have been postponed or also missed their price targets......»»

Category: topSource: bizjournalsMay 14th, 2021

Why F-star Therapeutics" Stock Is Trading Lower Today

F-star Therapeutics (NASDAQ:FSTX) shares are trading lower after the company priced its 9.29 million shares common stock offering at $7 per share. read more.....»»

Category: blogSource: benzingaMay 7th, 2021

F-star Therapeutics 9.286M share Secondary priced at $7.00

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 7th, 2021

F-star Therapeutics announces common stock offering, no amount given

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 6th, 2021

Rain Therapeutics raises $125M in 5th Bay Area life science IPO in 8 days

Rain Therapeutics Inc. was set on Friday to be the fifth Bay Area life science company in eight days to debut on Nasdaq. The Newark cancer therapeutics business raised $125 million in an initial public offering that hit the middle of its price .....»»

Category: topSource: bizjournalsApr 23rd, 2021

NeuBase Therapeutics 8M share Spot Secondary priced at $5.00

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 22nd, 2021

Summit Therapeutics announces commencement rights offering

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 21st, 2021

Investors Pick Up CRNX Even Cheaper Than Its Secondary Stock Offering

Dividend Channel.....»»

Category: topSource: redinewsApr 12th, 2021

Investors Grab AMRS Even Cheaper Than Its Secondary Stock Offering

Dividend Channel.....»»

Category: topSource: redinewsApr 12th, 2021

Addex Therapeutics files $150M share offering

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 7th, 2021